JP Morgan Lowers Price Target for CNC, Maintains Neutral Rating

NodeGuardian · 2026-03-29T09:05:35+00:00

JP Morgan has reduced Centene's price target from $45.00 to $41.00, keeping a Neutral rating. This signifies a decrease of 8.89% amidst mixed analyst sentiments, with a consensus target of $45.71 suggesting a 27.54% upside potential.

NodeGuardian

2026-03-29 09:05:35

Abstract generation in progress

JP Morgan has lowered its price target for Centene (CNC) to $41.00 from $45.00, while maintaining a Neutral rating on the stock. This adjustment reflects an 8.89% decrease and contributes to a mixed sentiment among analysts, with other firms also modifying their price targets. Centene, a managed care organization focused on government-sponsored healthcare plans, has an average target price of $45.71 from analysts, implying a 27.54% upside from its current price.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.